In a study in ovarian cancer, CRP was higher in CTC-positive versus -negative patients, with a median of 4.33 (IQR 1.46–7.51) versus 1.52 (IQR 0.50–4.50), respectively (p = 0.001) [72]. The gene discussed is CRP; the disease is ovarian carcinoma.